Reports of side-effects from Bayer’s Xarelto grow -Spiegel

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

Xarelto is used to reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem. There is limited information on how effective it is compared to warfarin (coumadin). The FDA approved it’s use in the US in November 2011.

A German magazine, Der Spiegel,  published an article about the extrordinary amount of reported side effects in Germany from the drug Xarelto. They state:

  • In 2013, for 8 months, 968 cases of (suspected) side effects, including 72 deaths.
  • In 2012, for the full year, 750 cases of side-effects, including 58 cases of death.

Bayer projects $2b in sales for Xarelto. Via Reuters

– MedShadow Staff


Did you find this article helpful?


Latest News

  • Advertisement